New pill aims to tame blood fats after Weight-Loss drug stop
Disease control
Completed
This study tested whether the drug RDX-002 can lower high blood fats (triglycerides) in adults who recently stopped taking semaglutide or tirzepatide for obesity. 68 participants took either RDX-002 or a placebo daily for 12 weeks. Researchers measured fat levels after a high-fat…
Phase: PHASE2 • Sponsor: Response Pharmaceuticals • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC